This is unpublished

Ajay K.

he, him, his
Physician & Research Faculty
Professor, Division of Hematology and Oncology, University of Washington
Professor, Clinical Research Division, Fred Hutchinson Cancer Center
Director of Clinical Research, Hematologic Malignancies/Hematology, Fred Hutch / UW Cancer Consortium
Associate Medical Director, Hematologic Malignancies/Hematology, Fred Hutch
Clinical Research Director, Hematologic Malignancies/Hematology, Myeloma and Lymphoma Oncology, UW Medicine
Stephen H. Petersdorf Endowed Chair in Cancer Care
Sites of Practice
Fred Hutchinson Cancer Center - South Lake Union

Photo: Fred Hutch

Education, Training, Board Certifications 

  • M.D., Emory University School of Medicine
  • Residency in Internal Medicine, Duke University  
  • Fellowship in Medical Oncology, Fred Hutch/UW 
  • Medical Oncology, American Board of Internal Medicine 
  • Internal Medicine, American Board of Internal Medicine

Clinical Expertise

  • Lymphoma 
  • Chronic lymphocytic leukemia (CLL)
  • Hematologic malignancies 
  • Hematopoietic stem cell transplantation
  • Cellular therapy
  • Radioimmunotherapy




Research and/or clinical interests

Dr. Ajay Gopal develops new targeted treatments for patients with lymphoma. He is director of clinical research in hematological malignancies and hematology at Fred Hutch.

Dr. Gopal’s research focuses on developing novel targeted therapies for lymphomas with particular emphasis on immunotherapeutic strategies, low toxicity, proapoptotic agents for indolent lymphomas, and safer regimens for older adults with lymphoma.